Physician profile
Bernard A Leech
NPI 1730407339
$1,501.91
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $59.53 · 2021: $96.83 · 2022: $449 · 2023: $349 · 2024: $50.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.38 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $337.60 | 2019-2023 | Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $264.98 | 2019-2023 | Mounjaro, Emgality, Jardiance |
| Novo Nordisk INC | $222.16 | 2019-2023 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $127.85 | 2019-2023 | Myrbetriq, Veozah |
| Abbvie INC. | $81.11 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.16 | 2021-2022 | |
| Pfizer INC. | $53.66 | 2019-2022 | |
| Abbott Laboratories | $51.83 | 2023 | Freestyle Libre 3, Proclaim |
| Alexion Pharmaceuticals, INC. | $50.00 | 2024 | Ultomiris |
| Astrazeneca Pharmaceuticals Lp | $42.58 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.38 | 2021-2022 | |
| Amgen INC. | $31.28 | 2019 | |
| Janssen Pharmaceuticals, INC | $29.14 | 2019-2022 | |
| Boston Scientific Corporation | $26.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $20.19 | 2023 | Eliquis |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $18.88 | 2023 | Zio Xt Patch |
| Merck Sharp & Dohme LLC | $15.19 | 2019 | |
| Exact Sciences Corporation | $13.73 | 2023 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Leech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.